Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Mar 31, 2025 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | (Q3)Dec 31, 2022 | (Q2)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 1.57%8.12B | -13.44%8B | -10.54%1.91B | -24.52%1.87B | -9.83%2.25B | -7.67%1.97B | 7.80%9.24B | -13.23%2.13B | 0.62%2.48B | 22.15%2.5B |
| Cost of revenue | 2.87%5.96B | -15.80%5.79B | -10.30%1.36B | -27.26%1.34B | -11.01%1.71B | -13.56%1.38B | 5.55%6.88B | -20.29%1.51B | -2.13%1.85B | 26.62%1.92B |
| Gross profit | -1.84%2.16B | -6.54%2.2B | -11.13%548.03M | -16.55%529.66M | -5.90%541.03M | 10.03%585.56M | 14.94%2.36B | 10.90%616.65M | 9.57%634.7M | 9.24%574.93M |
| Operating expense | -6.41%1.99B | 9.55%2.12B | -8.11%494.84M | -1.19%522.99M | 26.80%550.77M | 27.32%552.55M | 16.95%1.94B | 17.49%538.53M | 24.45%529.3M | 6.40%434.36M |
| Operating profit | 114.74%178.52M | -80.31%83.13M | -31.91%53.19M | -93.67%6.67M | -106.93%-9.74M | -66.39%33.01M | 6.57%422.3M | -20.01%78.12M | -31.52%105.4M | 19.08%140.57M |
| Net non-operating interest income (expenses) | 57.40%-2.16M | -88.50%-5.06M | 11.54%-1.11M | 9.99%-1.27M | -8,452.94%-1.42M | -3,502.86%-1.26M | -9,692.86%-2.69M | -9,761.54%-1.26M | -1.41M | 21.43%17K |
| Non-operating interest income | 5,157.69%1.37M | -29.73%26K | -136.84%-7K | --0 | 94.12%33K | --0 | 23.33%37K | 26.67%19K | --0 | 21.43%17K |
| Non-operating interest expense | -30.75%3.52M | 86.89%5.09M | -13.41%1.1M | -9.99%1.27M | --1.45M | 3,402.78%1.26M | 136,050.00%2.72M | 63,650.00%1.28M | --1.41M | --0 |
| Net investment income | -46.76%5.63M | 108.27%10.57M | -55.25%2.03M | -2.15M | 6.88M | 3.82M | 629.31%5.08M | 4.54M | ||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | 0 | 18.51%-27.86M | -27.86M | -34.19M | 0 | |||||
| Income from associates and other participating interests | 264.00%94.75M | -384.39%-57.77M | -65.12%8.61M | -272.19%-34.21M | -98.39%429K | -49.24%-32.61M | 95.11%20.32M | 128.78%24.7M | -0.60%-9.19M | 61.61%26.66M |
| Special income (charges) | -88.54%1.03M | 264.06%8.98M | -81.25%30K | 100.52%30K | 29,530.00%8.89M | -75.00%30K | -165.50%-5.47M | -98.06%160K | -19,376.67%-5.78M | 0.00%30K |
| Less:Restructuring and mergern&acquisition | ---- | --0 | --0 | ---- | ---- | ---- | ---1.64M | --0 | ---- | ---- |
| Less:Other special charges | 89.74%-909K | -218.42%-8.86M | --0 | --0 | ---- | ---- | 212.26%7.48M | --0 | ---- | ---- |
| Less:Write off | 0.00%-120K | 67.12%-120K | 81.25%-30K | 45.45%-30K | 0.00%-30K | 75.00%-30K | 78.43%-365K | 90.01%-160K | -83.33%-55K | 0.00%-30K |
| Other non-operating income (expenses) | 48.32%16.11M | 9.92%10.86M | -33.41%4.09M | 126.67%3.54M | 237.11%484K | 8.70%2.75M | 202.23%9.88M | 71.00%6.14M | 1,051.22%1.56M | -71.36%-353K |
| Income before tax | 1,185.88%293.88M | -94.50%22.85M | -65.31%38.99M | -148.12%-27.39M | -96.69%5.52M | -92.74%5.74M | -0.90%415.22M | -6.59%112.4M | -60.65%56.92M | 24.01%166.92M |
| Income tax | 151.39%53.82M | -81.66%21.41M | 96.61%-210K | -107.88%-2.94M | -88.36%6.62M | -37.56%17.95M | -11.31%116.74M | -123.66%-6.2M | -30.75%37.38M | 40.71%56.82M |
| Net income | 16,524.10%240.05M | -99.52%1.44M | -66.95%39.2M | -225.05%-24.45M | -101.00%-1.1M | -124.31%-12.21M | 3.86%298.48M | 26.00%118.6M | -78.44%19.55M | 16.85%110.1M |
| Net income continuous operations | 16,524.17%240.05M | -99.52%1.44M | -66.95%39.2M | -225.05%-24.45M | -101.00%-1.1M | -124.31%-12.21M | 3.86%298.48M | 26.00%118.6M | -78.44%19.55M | 16.85%110.1M |
| Noncontrolling interests | 4,379.71%46.37M | 126.12%1.04M | -159.71%-1.75M | 325.37%12.02M | -132.46%-6.37M | -342.28%-2.87M | 77.65%-3.96M | 79.83%2.92M | 55.17%-5.33M | 41.39%-2.74M |
| Net income attributable to the company | 47,372.06%193.69M | -99.87%408K | -64.60%40.95M | -246.56%-36.47M | -95.33%5.27M | -119.05%-9.34M | -0.87%302.45M | 25.05%115.68M | -75.74%24.88M | 14.10%112.84M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 47,372.06%193.69M | -99.87%408K | -64.60%40.95M | -246.56%-36.47M | -95.33%5.27M | -119.05%-9.34M | -0.87%302.45M | 25.05%115.68M | -75.74%24.88M | 14.10%112.84M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 46,457.14%65.18 | -99.85%0.14 | -62.54%13.8 | -258.79%-12.29 | -94.92%1.78 | -120.67%-3.15 | 0.06%94.89 | 28.14%36.84 | -75.72%7.74 | 14.09%35.07 |
| Diluted earnings per share | 46,357.14%65.04 | -99.85%0.14 | -62.45%13.7985 | -259.40%-12.29 | -94.92%1.7759 | -120.72%-3.15 | 0.06%94.65 | 28.14%36.75 | -75.75%7.71 | 14.12%34.99 |
| Dividend per share | 31.82%29 | -45.00%22 | -45.00%22 | 0 | 0 | 0 | 8.11%40 | 8.11%40 | 0 | 0 |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |